DIGITAL-KNEE Study: Adequately Diagnosing Total Knee Arthroplasty Loosening by Evaluating the AtMoves Knee System in a Routine Clinical Setting

Recruiting now · Not applicable

Conditions studied: Aseptic Loosening, Aseptic Loosening of Prosthetic Joint, Aseptic Loosening of Orthopaedic Hardware, Knee Arthroplasty, Total, Total Knee Arthroplasty (Replacement)

In brief

The goal of the clinical trial is to evaluate the efficacy of the AtMoves Knee System in the clinical diagnostic process of aseptic loosening in patients with a knee prosthesis. The main question it aims to answer is: Does the use of the AtMoves Knee System reduce the percentage of failed outcomes? A "failed outcome" is defined as a change in the patient-reported Knee injury and Osteoarthritis Outcome Score (KOOS-PS) that is lower than the minimal clinically important difference at 12 months. Researchers will compare two groups: The first group will undergo an additional CT scan using the AtMoves Knee System. The second group will not undergo these scans. Both groups are allowed to undergo additional diagnostic measures. Researchers will compare the percentage of "failed outcomes" between these groups. During the one-year follow-up, participants in both groups will be asked to fill out questionnaires.

Key facts

Study ID

NCT06839807

Run by

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

People needed

124

Starts

2025-02-01

Expected to finish

2026-06-01

Last updated by the study team

2025-02-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older.
• Subjects must have underwent either unilateral or bilateral TKA surgery.
• Aseptic loosening is one of the differential diagnoses of the treating orthopaedic surgeon
• The treating Orthopaedic Surgeon is uncertain of the diagnosis after anamnesis, physical examination and conventional x-ray.
• The surgeon wants additional examinations or additional imaging to arrive at the diagnosis and proposal for treatment.
• Subjects must be capable of giving informed consent and must be willing to undergo examination with the AtMoves Knee System.

You may not qualify if…

• A clear other cause for complaints other than aseptic loosening (e.g. septic loosening, neuropathic pain, non-consolidated peri-prosthetic fracture of the bone around the TKA)
• Surgical interventions of the index knee in the year prior to the start of the complaints associated with TKA loosening.
• Posttraumatic or congenital deformation of the leg for which the loading device does not fit.
• Pregnancy or suspected pregnancy.
• Unable or unwilling to understand or sign the informed consent for this study and to undergo examination with the AtMoves Knee System.

Where it is running

• Amsterdam UMC — Amsterdam, North Holland, Netherlands (enrolling)
• Zuyderland Ziekenhuis — Heerlen, Limburg, Netherlands
• Amphia ziekenhuis — Breda, North Brabant, Netherlands
• St. Maartenskliniek — Nijmegen, Gelderland, Netherlands
• OCON — Hengelo, Overijsel, Netherlands
• NoordWest Ziekenhuisgroep — Alkmaar, Netherlands
• Elisabeth-TweeSteden Ziekenhuis — Tilburg, Netherlands

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.